Quantum BioPharma (XCNQ:QNTM) EPS (Basic): C$-11.32 (TTM As of Mar. 2026)


XCNQ:QNTM Quantum BioPharma Ltd XCNQ:QNTM
22 GF Score
Price C$5.36
! 5 Warning Signs
View Full Analysis

What is Quantum BioPharma EPS (Basic)?

Quantum BioPharma XCNQ:QNTM -4.29% 22 EPS (Basic) is C$-11.32 as of Mar. 2026. GuruFocus rates XCNQ:QNTM with a GF Score™ of 22/100. The stock has 5 warning signs investors should review.

Quantum BioPharma's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was C$-4.20. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was C$-11.32.

Quantum BioPharma's EPS (Diluted) for the three months ended in Mar. 2026 was C$-4.20. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was C$-11.32.

Quantum BioPharma's EPS without NRI for the three months ended in Mar. 2026 was C$-1.59. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -5.18.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Quantum BioPharma  (XCNQ:QNTM) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Quantum BioPharma EPS (Basic) Related Terms

Quantum BioPharma EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Quantum BioPharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quantum BioPharma EPS (Basic) Chart

Quantum BioPharma Annual Data
Trend Aug16 Aug17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -84.03 -53.81 -40.15 -18.69 -11.31

Quantum BioPharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.07 -4.42 -1.73 -0.98 -4.20
XCNQ:QNTM
22GF Score
Quantum BioPharma Ltd XCNQ:QNTM
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quantum BioPharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Quantum BioPharma's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-36.108-0)/3.286
=-10.99

Quantum BioPharma's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-18.604-0)/4.489
=-4.14

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-11.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of C$-11.32 mean?
Quantum BioPharma (XCNQ:QNTM) has a EPS (Basic) of C$-11.32 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Quantum BioPharma and its competitors.
Is Quantum BioPharma's EPS (Basic) too high?
Quantum BioPharma's current EPS (Basic) is C$-11.32. Overall, Quantum BioPharma has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Quantum BioPharma's EPS (Basic) compare to VRTX and REGN?
Quantum BioPharma's EPS (Basic) of C$-11.32 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Quantum BioPharma and its competitors. Quantum BioPharma's current EPS (Basic) is C$-11.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quantum BioPharma stock overvalued right now?
Quantum BioPharma (XCNQ:QNTM) has a current EPS (Basic) of C$-11.32. The current EPS (Basic) is C$-11.32. Quantum BioPharma's overall GF Score™ is 22/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Quantum BioPharma (XCNQ:QNTM), the current EPS (Basic) is C$-11.32 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quantum BioPharma Business Description

Other Exchanges QNTM:USA0K91:Germany
Address 1 Adelaide Street East, Suite 801, Toronto, ON, CAN, M5C 2V9
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
22GF Score

Get the complete analysis for XCNQ:QNTM

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$5.36
Price